FDA Inspection 1062283 — Zhejiang Huahai Pharmaceutical
The FDA completed an inspection of Zhejiang Huahai Pharmaceutical on Aug 3, 2018 in Linhai. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Aug 3, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Linhai (China)